Med List - Yola



Updated 7/21/04

This is a huge list that was compiled from the work of numerous students. Designed to be a resource for care plan drug lists, there are duplicates of popular drugs or drugs that have more than one use. Use at your own risk.

Drugs are listed here alphabetically by generic name, trade name, or both. Try searching for both names before going to the trouble of making a new entry.

To find a drug on this list, press the key combination Ctrl-F (Control-F), type the name of the drug you are looking for and press enter. Each subsequent time you press enter the next entry of the drug will be shown.

Some drugs may be listed many times in the Side Effects and Nursing Implications, which can be aggravating when using Ctrl-F. To limit the search to the first column (Drug Name), highlight that column by clicking the column's top gridline or border. The column will turn black to show it is selected. Then press Ctrl-F.

Other useful key combinations are Ctrl-Home and Ctrl-End.

|Drug Name |Class |Actions |Indications |Side Effects |Nursing implications |

|Abciximab |Inhibits platelet aggregation by |Adjunct to aspirin and heparin for | |Bleeding, including intracranial, |Monitor for S&S of: bleeding; |

|(ReoPro) |preventing fibrinogen, von |the prevention of acute cardiac | |retroperitoneal, and hematemesis; |hypersensitivity. |

| |Willebrand's factor, and other |ischemic complications in patients | |thrombocytopenia |Monitor Hgb, Hct, platelet count, |

| |molecules from adhering to |undergoing percutaneous | | |PT, APTT, INR, every 2–4 h during |

| |GPIIb/IIIa receptor sites of the |transluminal coronary angioplasty | | |first 24 h. |

| |platelets. |(PTCA). | | |Bleeding precautions. |

|Accuzyme Ointment |Indicated for debridement of |Papain, the proteolytic enzyme from| |Generally well tolerated and |Avoid cleansing with hydrogen |

|Papain-Urea 1.1 x106Unit/gm |necrotic tissue and liquefaction of|papaya, is a potent digestant of | |non-irritating. A transient |peroxide solution as it may |

| |slough in acute and chronic lesions|nonviable protein matter but is | |"burning" sensation may be |inactivate the papain. |

| |such as pressure ulcers, varicose |harmless to viable tissue. In | |experienced by a small percentage |Apply directly to the wound, cover |

| |and diabetic ulcers, burns, |Accuzyme, papain is combined with | |of patients upon applying Accuzyme.|with appropriate dressing, secure |

| |postoperative wounds, pilonidal |urea, a denaturant of proteins. | |Occasionally, the profuse exudate |into place. |

| |cyst wounds, carbuncles and |Pharmacologic studies have shown | |from enzymatic digestion may |Daily or twice daily applications |

| |miscellaneous traumatic or infected|that the combination of papain and | |irritate the skin. In such cases, |are preferred. |

| |wounds. |urea result in twice as much | |more frequent dressing changes will|Irrigate the wound at each |

| | |digestive activity as papain alone.| |alleviate discomfort until exudate |redressing to remove any |

| | | | |decreases. |accumulation of liquefied necrotic |

| | | | | |material. |

| | | | | |Papain may be inactivated by the |

| | | | | |salts of heavy metals such as lead,|

| | | | | |silver and mercury. Contact with |

| | | | | |medications containing these metals|

| | | | | |should be avoided. |

|Acetaminophen |Nonnarcotic Analgesic; |May block pain impulses | |N&V, abd. pain, hepatoxicity, |Liver function test, renal |

| |Non-salicylate, Paraminophenol |peripherally that occur in response| |stimulation, drowsiness, |function, CBC, fever or pain, I&O, |

| |Derivate Use antipyretic, |to inhibition of prostaglandin | |leukopenia, anemia, |chronic poisoning, hepatotoxicity, |

| |analgesic, treat viral infections |synthesis: antipyretic action from | |thrombocytopenia, pancytopenia, |allergic reaction |

| | |inhibition of prost CNS | |rash, angioedema, anaphylaxis |Peak: 0.5–2 h. Duration: 3–4 h |

|Acetaminophen (Tylenol) |non-narcotic analgesic |produces analgesia, reduces fever | |hepatotoxic |monitor ALT, AST |

|650 mg PO q 8 h |relief for mild pain |by direct action of hypothalamus | |elevation of ALT, AST |monitor for S/S of hepatotoxicity |

|Acetazolamide (diamox ) |Carbonic anhydrase inhibitor, |Inhibits CNS carbonic anhydrase, |Antileptic |Sedation, paresthesia, |Caution with diabetes and |

| |diuretic, CNS agent, anticonvulsant|which retards abnormal discharge | |pancytopenia, hyperglycemia, muscle|obstructive pulmonary disease. give|

| |Use: treat glaucoma, reduce seizure|from CNS neurons, inhibits carbonic| |weakness |with food, does not dissolve in |

| |activity, |anhydrase activity in the proximal | | |fruit juice |

| | |convoluted tubule, preventing the | | | |

| | |formation of carbonic acid, which | | | |

| | |enhances diuresis, inhibits aqueous| | | |

| | |humor production to lower | | | |

| | |intraocular pressure of glaucoma. | | | |

|Adriamycin, Doxorubicin |antibiotic antineoplastic |interferes with DNA and RNA |Hodgkin’s, Wilms tumor, and other |arrhythmias, acute left ventricular|cardiac function test, adequate |

|hydrochloride | |synthesis |types of cancer |failure, irreversible |hydration, premed with antiemetics,|

| | | | |cardiomyopathy, leukopenia, |never give drug IM or SQ, CBC, WBC,|

| | | | |thrombocytopenia, anaphylaxis, |monitor for signs of heart failure |

| | | | |cellulitis, tissue sloughing, |and dc if noted, wear protective |

| | | | |complete alopecia, transient red |equipment when handling |

| | | | |urine, GI effects | |

|Albumin |blood derivative |expands blood volume |hypovolemic shock, hypoproteinemia,|ha, vascular overload, ................
................